EARLY_POD_1-ai

0:00

S… Speaker 1 (EARLY_POD_1-ai)

All right,

0:00

S… Speaker 1 (EARLY_POD_1-ai)

Dr.

0:01

S… Speaker 1 (EARLY_POD_1-ai)

Ratul, you are the leading minds in the country about all things GLP -1,

0:05

S… Speaker 1 (EARLY_POD_1-ai)

weight loss and related.

0:06

S… Speaker 1 (EARLY_POD_1-ai)

Thank you so much for joining us.

0:08

S… Speaker 2 (EARLY_POD_1-ai)

Thank you.

0:10

S… Speaker 2 (EARLY_POD_1-ai)

Thank you for I will be here.

0:11

S… Speaker 1 (EARLY_POD_1-ai)

Of course.

0:11

S… Speaker 1 (EARLY_POD_1-ai)

Please introduce yourself.

0:13

S… Speaker 2 (EARLY_POD_1-ai)

I am Dr.

0:14

S… Speaker 2 (EARLY_POD_1-ai)

Atun Dhingra.

0:15

S… Speaker 2 (EARLY_POD_1-ai)

I am an endocrinologist currently practicing in Srinagaragar.

0:19

S… Speaker 2 (EARLY_POD_1-ai)

And I'm also heading a department of epidemiology at Dr.

0:22

S… Speaker 1 (EARLY_POD_1-ai)

S. S.

0:22

S… Speaker 2 (EARLY_POD_1-ai)

Tantia Medical College in Stigel.

0:24

S… Speaker 1 (EARLY_POD_1-ai)

Amazing.

0:25

S… Speaker 1 (EARLY_POD_1-ai)

So, let's start from here.

0:26

S… Speaker 1 (EARLY_POD_1-ai)

What are GLP medications and how are weight loss?

0:30

S… Speaker 2 (EARLY_POD_1-ai)

So,

0:31

S… Speaker 2 (EARLY_POD_1-ai)

GLP -1 is a hormone.

0:35

S… Speaker 2 (EARLY_POD_1-ai)

Today, we thought that the weight that we eat

0:39

S… Speaker 2 (EARLY_POD_1-ai)

and that we don't eat,

0:40

S… Speaker 2 (EARLY_POD_1-ai)

is the difference.

0:41

S… Speaker 2 (EARLY_POD_1-ai)

But actually,

0:42

S… Speaker 2 (EARLY_POD_1-ai)

when we had a psychiatric surgery,

0:43

S… Speaker 2 (EARLY_POD_1-ai)

we understood that this is only the change of

0:48

S… Speaker 2 (EARLY_POD_1-ai)

eating. This is our mind of a hormone system problem.

0:51

S… Speaker 2 (EARLY_POD_1-ai)

When we have a psychiatric surgery,

0:53

S… Speaker 2 (EARLY_POD_1-ai)

we have a GLP -1 hormone in it.

0:57

S… Speaker 2 (EARLY_POD_1-ai)

When we have a research on this research,

1:00

S… Speaker 2 (EARLY_POD_1-ai)

we have made it out of our patients.

1:16

S… Speaker 1 (EARLY_POD_1-ai)

All right.

1:16

S… Speaker 1 (EARLY_POD_1-ai)

Wow. Sounds very powerful.

1:18

S… Speaker 1 (EARLY_POD_1-ai)

So, how much weight loss can be for obese people?

1:21

S… Speaker 2 (EARLY_POD_1-ai)

It depends on which molecules you choose.

1:24

S… Speaker 2 (EARLY_POD_1-ai)

Today we have many molecules available.

1:27

S… Speaker 2 (EARLY_POD_1-ai)

Today we have two molecules available.

1:30

S… Speaker 2 (EARLY_POD_1-ai)

One is Tuz Hepatite,

1:31

S… Speaker 2 (EARLY_POD_1-ai)

which is known as Muzaro.

1:32

S… Speaker 2 (EARLY_POD_1-ai)

The other is Simogiptrice.

1:34

S… Speaker 2 (EARLY_POD_1-ai)

There are many generics available in the market.

1:37

S… Speaker 2 (EARLY_POD_1-ai)

From zero,

1:38

S… Speaker 2 (EARLY_POD_1-ai)

the data tells us that it is 20 to 25 %

1:42

S… Speaker 2 (EARLY_POD_1-ai)

weight reduction.

1:43

S… Speaker 2 (EARLY_POD_1-ai)

If you reach maximum tolerated dose,

1:45

S… Speaker 2 (EARLY_POD_1-ai)

it is 10 to 15 %

1:49

S… Speaker 2 (EARLY_POD_1-ai)

weight reduction.

1:50

S… Speaker 2 (EARLY_POD_1-ai)

But if you can increase the dose,

1:51

S… Speaker 2 (EARLY_POD_1-ai)

it is 20 % weight reduction.

1:55

S… Speaker 1 (EARLY_POD_1-ai)

And how much weight loss can you

1:59

S… Speaker 1 (EARLY_POD_1-ai)

achieve?

2:03

S… Speaker 2 (EARLY_POD_1-ai)

Usually over M .E .R.

2:07

S… Speaker 2 (EARLY_POD_1-ai)

In clinics,

2:08

S… Speaker 2 (EARLY_POD_1-ai)

we have different weight reductions.

2:10

S… Speaker 2 (EARLY_POD_1-ai)

Some patients have a lot of weight loss.

2:12

S… Speaker 2 (EARLY_POD_1-ai)

Some patients have a lot of weight loss.

2:13

S… Speaker 2 (EARLY_POD_1-ai)

Some patients have a lot of weight loss.

2:14

S… Speaker 2 (EARLY_POD_1-ai)

So your genetics will depend on it,

2:16

S… Speaker 2 (EARLY_POD_1-ai)

but usually it will take a year.

2:17

S… Speaker 2 (EARLY_POD_1-ai)

Got it.

2:18

S… Speaker 1 (EARLY_POD_1-ai)

So, if someone takes weight loss for 6 months,

2:22

S… Speaker 1 (EARLY_POD_1-ai)

9 months,

2:23

S… Speaker 1 (EARLY_POD_1-ai)

1 year, they add up.

2:26

S… Speaker 1 (EARLY_POD_1-ai)

So,

2:27

S… Speaker 1 (EARLY_POD_1-ai)

how do you guide this investment?

2:29

S… Speaker 1 (EARLY_POD_1-ai)

So,

2:32

S… Speaker 2 (EARLY_POD_1-ai)

if you think about long term,

2:37

S… Speaker 2 (EARLY_POD_1-ai)

If we have 50 to 20 % weight reduction,

2:40

S… Speaker 2 (EARLY_POD_1-ai)

then we have a lot of chances of heart problems.

2:43

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of chances of osteoarthritis.

2:47

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of chances of osteoarthritis.

2:49

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of sleep.

2:50

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of sleep.

2:52

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of sleep.

2:53

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of sleep.

2:55

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of sleep.

2:57

S… Speaker 2 (EARLY_POD_1-ai)

We have a lot of

3:03

S… Speaker 1 (EARLY_POD_1-ai)

sleep.

3:03

S… Speaker 2 (EARLY_POD_1-ai)

These things we were not able to do before.

3:05

S… Speaker 2 (EARLY_POD_1-ai)

So overall cost is very easy.

3:08

S… Speaker 1 (EARLY_POD_1-ai)

All those costs will be very easy

3:12

S… Speaker 1 (EARLY_POD_1-ai)

and uncomfortable.

3:15

S… Speaker 1 (EARLY_POD_1-ai)

So if we talk about cost,

3:19

S… Speaker 1 (EARLY_POD_1-ai)

GLP -1's of many Indian variants,

3:21

S… Speaker 1 (EARLY_POD_1-ai)

we are saying generic question.

3:33

S… Speaker 2 (EARLY_POD_1-ai)

So India is actually called world's pharmacy.

3:36

S… Speaker 2 (EARLY_POD_1-ai)

We are able

3:40

S… Speaker 2 (EARLY_POD_1-ai)

to produce medications at a very low cost.

3:43

S… Speaker 2 (EARLY_POD_1-ai)

And same holds true for simaglutida as well.

3:49

S… Speaker 2 (EARLY_POD_1-ai)

All of these molecules have gone through request rates.

4:02

S… Speaker 2 (EARLY_POD_1-ai)

So I believe RDCJ is doing a good job.

4:04

S… Speaker 1 (EARLY_POD_1-ai)

And this medication is not only in India,

4:06

S… Speaker 1 (EARLY_POD_1-ai)

in fact,

4:07

S… Speaker 2 (EARLY_POD_1-ai)

going abroad. So I again,

4:10

S… Speaker 2 (EARLY_POD_1-ai)

I hold my hope.

4:12

S… Speaker 2 (EARLY_POD_1-ai)

I come to my same statement that India is world's pharmacy and this

4:16

S… Speaker 2 (EARLY_POD_1-ai)

is going to be.

4:17

S… Speaker 2 (EARLY_POD_1-ai)

True for this model.

4:18

S… Speaker 1 (EARLY_POD_1-ai)

Okay. And now,

4:20

S… Speaker 1 (EARLY_POD_1-ai)

these generic generic versions are going to see many brands.

4:23

S… Speaker 1 (EARLY_POD_1-ai)

So,

4:25

S… Speaker 1 (EARLY_POD_1-ai)

in these brands, there will be differences in many cases.

4:28

S… Speaker 1 (EARLY_POD_1-ai)

What do you think mostly similar?

4:29

S… Speaker 2 (EARLY_POD_1-ai)

So,

4:30

S… Speaker 2 (EARLY_POD_1-ai)

we should definitely know about these all molecules.

4:33

S… Speaker 2 (EARLY_POD_1-ai)

When you have to use a molecule,

4:36

S… Speaker 2 (EARLY_POD_1-ai)

how it is produced,

4:38

S… Speaker 2 (EARLY_POD_1-ai)

what is the purification process,

4:40

S… Speaker 2 (EARLY_POD_1-ai)

what is the data behind it.

4:42

S… Speaker 2 (EARLY_POD_1-ai)

If you understand all of these things,

4:44

S… Speaker 2 (EARLY_POD_1-ai)

then use it.

4:45

S… Speaker 2 (EARLY_POD_1-ai)

How do you think it's properly?

4:47

S… Speaker 1 (EARLY_POD_1-ai)

Okay, my next question is that the GLP

4:52

S… Speaker 1 (EARLY_POD_1-ai)

-1 medication is written as an endocrinologist

4:56

S… Speaker 1 (EARLY_POD_1-ai)

or an internal medicine specialist.

5:00

S… Speaker 2 (EARLY_POD_1-ai)

We can see that every type of doctor is prescribed.

5:02

S… Speaker 3 (EARLY_POD_1-ai)

We only see the problems.

5:04

S… Speaker 3 (EARLY_POD_1-ai)

We only see the effects.

5:06

S… Speaker 3 (EARLY_POD_1-ai)

But we also see the problems.

5:09

S… Speaker 3 (EARLY_POD_1-ai)

Like gastric issues.

5:12

S… Speaker 3 (EARLY_POD_1-ai)

Nausea,

5:13

S… Speaker 3 (EARLY_POD_1-ai)

vomiting, diarrhea,

5:14

S… Speaker 3 (EARLY_POD_1-ai)

constipation.

5:15

S… Speaker 3 (EARLY_POD_1-ai)

These problems you can manage medically.

5:18

S… Speaker 3 (EARLY_POD_1-ai)

Especially when you are giving a diabetic patient and

5:22

S… Speaker 3 (EARLY_POD_1-ai)

diarrhea.

5:23

S… Speaker 3 (EARLY_POD_1-ai)

Then you will get a doctor who will

5:27

S… Speaker 3 (EARLY_POD_1-ai)

see all the problems.

5:29

S… Speaker 3 (EARLY_POD_1-ai)

which can only treat your diarrhea.

5:30

S… Speaker 3 (EARLY_POD_1-ai)

Now,

5:32

S… Speaker 3 (EARLY_POD_1-ai)

with that diarrhea, your sugars are low and you need to go down to sugar.

5:36

S… Speaker 3 (EARLY_POD_1-ai)

You can go down to hypoglycemia.

5:37

S… Speaker 3 (EARLY_POD_1-ai)

You can change electrolytes.

5:39

S… Speaker 3 (EARLY_POD_1-ai)

This is why the package is written on internal medicine

5:43

S… Speaker 1 (EARLY_POD_1-ai)

specialist.

5:43

S… Speaker 1 (EARLY_POD_1-ai)

Obviously,

5:45

S… Speaker 2 (EARLY_POD_1-ai)

people are very cost sensitive.

5:49

S… Speaker 2 (EARLY_POD_1-ai)

Price sensitivity is very high.

5:52

S… Speaker 2 (EARLY_POD_1-ai)

There are many cases where people

5:56

S… Speaker 2 (EARLY_POD_1-ai)

buy TRP -1 medications in pharmacies.

5:59

S… Speaker 2 (EARLY_POD_1-ai)

If you want to take a prescription,

6:00

S… Speaker 2 (EARLY_POD_1-ai)

if you want to take these things,

6:03

S… Speaker 2 (EARLY_POD_1-ai)

what is needed?

6:05

S… Speaker 1 (EARLY_POD_1-ai)

So,

6:06

S… Speaker 3 (EARLY_POD_1-ai)

we need to keep a government case with surveillance because there

6:10

S… Speaker 3 (EARLY_POD_1-ai)

are no such damage to which problems are not created.

6:13

S… Speaker 3 (EARLY_POD_1-ai)

If they manage them in the right way,

6:15

S… Speaker 3 (EARLY_POD_1-ai)

if they manage them in the right way,

6:17

S… Speaker 3 (EARLY_POD_1-ai)

if they manage them in the right way, if they give them the right patients.

6:32

S… Speaker 3 (EARLY_POD_1-ai)

So if we talk about

6:38

S… Speaker 1 (EARLY_POD_1-ai)

side effects,

6:39

S… Speaker 2 (EARLY_POD_1-ai)

such as GI side effects,

6:41

S… Speaker 2 (EARLY_POD_1-ai)

people are talking a lot

6:46

S… Speaker 2 (EARLY_POD_1-ai)

about three things.

6:48

S… Speaker 2 (EARLY_POD_1-ai)

GLP -1's pancreatitis,

6:50

S… Speaker 2 (EARLY_POD_1-ai)

GLP -1's blindness and GLP -1's thyroid cancer.

6:54

S… Speaker 1 (EARLY_POD_1-ai)

So,

6:55

S… Speaker 3 (EARLY_POD_1-ai)

when I talk to my patients,

6:58

S… Speaker 3 (EARLY_POD_1-ai)

I will tell them

7:03

S… Speaker 3 (EARLY_POD_1-ai)

that GLP -1's pancreatitis or pancreatic

7:07

S… Speaker 3 (EARLY_POD_1-ai)

cancer or eye problem or blindness.

7:22

S… Speaker 3 (EARLY_POD_1-ai)

So if you look at the actual numbers,

7:25

S… Speaker 3 (EARLY_POD_1-ai)

these are very less numbers.

7:36

S… Speaker 3 (EARLY_POD_1-ai)

Even obesity in Na1 and IFTs in

7:40

S… Speaker 3 (EARLY_POD_1-ai)

Na1 incidence of Na1,

7:41

S… Speaker 3 (EARLY_POD_1-ai)

so is it the immediate reduction of drugs or something else?

7:45

S… Speaker 3 (EARLY_POD_1-ai)

We also try to understand this.

7:46

S… Speaker 3 (EARLY_POD_1-ai)

Similarly for medullary cancer,

7:49

S… Speaker 3 (EARLY_POD_1-ai)

the thyroid cancer is the latest publication of the last week

7:54

S… Speaker 3 (EARLY_POD_1-ai)

that practically it is not a risk associated with

7:58

S… Speaker 1 (EARLY_POD_1-ai)

the GMP1.

7:59

S… Speaker 3 (EARLY_POD_1-ai)

And pancreatitis,

8:01

S… Speaker 3 (EARLY_POD_1-ai)

if someone has pancreatitis,

8:10

S… Speaker 3 (EARLY_POD_1-ai)

Other than that pancreatitis caress is very complex.

8:14

S… Speaker 2 (EARLY_POD_1-ai)

So can you give GLP -1 use pancreatitis?

8:17

S… Speaker 1 (EARLY_POD_1-ai)

Very rare,

8:18

S… Speaker 1 (EARLY_POD_1-ai)

very rare.

8:20

S… Speaker 3 (EARLY_POD_1-ai)

Over past 20 years.

8:22

S… Speaker 3 (EARLY_POD_1-ai)

So I have started using liragrutide way back in 2009 and it is

8:27

S… Speaker 3 (EARLY_POD_1-ai)

2026 now.

8:29

S… Speaker 3 (EARLY_POD_1-ai)

I can't even remember seeing issues.

8:30

S… Speaker 3 (EARLY_POD_1-ai)

If you're using it again,

8:33

S… Speaker 3 (EARLY_POD_1-ai)

like you asked me,

8:34

S… Speaker 3 (EARLY_POD_1-ai)

if you're using it for the correct indication,

8:37

S… Speaker 3 (EARLY_POD_1-ai)

if you're using it in the correct patient,

8:38

S… Speaker 1 (EARLY_POD_1-ai)

you're not taking that.

8:40

S… Speaker 4 (EARLY_POD_1-ai)

Okay.

8:40

S… Speaker 2 (EARLY_POD_1-ai)

So results

8:47

S… Speaker 3 (EARLY_POD_1-ai)

have been really cut.

8:48

S… Speaker 3 (EARLY_POD_1-ai)

Results are actually

8:52

S… Speaker 3 (EARLY_POD_1-ai)

gratifying not only in the patient's weight loss,

8:55

S… Speaker 3 (EARLY_POD_1-ai)

but I can actually see life coming back to them.

8:58

S… Speaker 3 (EARLY_POD_1-ai)

A mother has started playing with the daughter again.

9:02

S… Speaker 3 (EARLY_POD_1-ai)

So that was something that I heard.

9:04

S… Speaker 3 (EARLY_POD_1-ai)

That was a story in my clinic.

9:06

S… Speaker 3 (EARLY_POD_1-ai)

A 142 KT girl.

9:09

S… Speaker 3 (EARLY_POD_1-ai)

Now she is 108.

9:10

S… Speaker 3 (EARLY_POD_1-ai)

And she actually told me,

9:12

S… Speaker 3 (EARLY_POD_1-ai)

sir, my relationships are so good.

9:14

S… Speaker 3 (EARLY_POD_1-ai)

So actually the molecule works really well.

9:18

S… Speaker 3 (EARLY_POD_1-ai)

And what happens with these molecules is that one of my

9:22

S… Speaker 3 (EARLY_POD_1-ai)

patients who took TLC1 from me,

9:25

S… Speaker 3 (EARLY_POD_1-ai)

she went to a marriage and actually I got six more patients after that.

9:29

S… Speaker 1 (EARLY_POD_1-ai)

They asked,

9:31

S… Speaker 1 (EARLY_POD_1-ai)

what have you done?

9:32

S… Speaker 1 (EARLY_POD_1-ai)

What is changing your life?

9:34

S… Speaker 1 (EARLY_POD_1-ai)

It can be life -changing.

9:36

S… Speaker 3 (EARLY_POD_1-ai)

You can actually see the results.

9:39

S… Speaker 1 (EARLY_POD_1-ai)

Wow,

9:40

S… Speaker 2 (EARLY_POD_1-ai)

that's really powerful.

9:41

S… Speaker 2 (EARLY_POD_1-ai)

What is your message to all?

9:45

S… Speaker 2 (EARLY_POD_1-ai)

overweight or obese people who feel any kind of stigma

9:49

S… Speaker 2 (EARLY_POD_1-ai)

or judgment around using GLP -1s?

9:53

S… Speaker 1 (EARLY_POD_1-ai)

See,

9:54

S… Speaker 3 (EARLY_POD_1-ai)

what I'll say is meet a qualified person.

9:58

S… Speaker 3 (EARLY_POD_1-ai)

Meet a qualified person who can actually guide you,

10:01

S… Speaker 3 (EARLY_POD_1-ai)

whether you want,

10:03

S… Speaker 3 (EARLY_POD_1-ai)

whether you'll be requiring or you'll not be requiring,

10:05

S… Speaker 3 (EARLY_POD_1-ai)

that will depend on your clinical status at that time.

10:12

S… Speaker 3 (EARLY_POD_1-ai)

If you have a need for it,

10:15

S… Speaker 3 (EARLY_POD_1-ai)

then you should take it.

10:16

S… Speaker 3 (EARLY_POD_1-ai)

Because in long run,

10:18

S… Speaker 3 (EARLY_POD_1-ai)

obesity problems are bigger than GLP

10:22

S… Speaker 3 (EARLY_POD_1-ai)

-1. Like many people

10:27

S… Speaker 2 (EARLY_POD_1-ai)

who are obese or overweight,

10:29

S… Speaker 2 (EARLY_POD_1-ai)

they say that they naturally try

10:34

S… Speaker 2 (EARLY_POD_1-ai)

to see.

10:37

S… Speaker 2 (EARLY_POD_1-ai)

So, I

10:43

S… Speaker 3 (EARLY_POD_1-ai)

always tend to agree with that.

10:44

S… Speaker 3 (EARLY_POD_1-ai)

I never say,

10:46

S… Speaker 1 (EARLY_POD_1-ai)

don't do this.

10:47

S… Speaker 3 (EARLY_POD_1-ai)

Why I say so is,

10:49

S… Speaker 3 (EARLY_POD_1-ai)

because lifestyle modifications,

10:51

S… Speaker 3 (EARLY_POD_1-ai)

I always want patients to know GLP.

10:53

S… Speaker 3 (EARLY_POD_1-ai)

I definitely tell them,

10:55

S… Speaker 3 (EARLY_POD_1-ai)

yes, I am with you,

10:57

S… Speaker 1 (EARLY_POD_1-ai)

and I am with you,

10:58

S… Speaker 1 (EARLY_POD_1-ai)

and I will tell you.

10:59

S… Speaker 3 (EARLY_POD_1-ai)

We will go

11:03

S… Speaker 3 (EARLY_POD_1-ai)

through this journey together.

11:04

S… Speaker 3 (EARLY_POD_1-ai)

And let's look at the results at 12 weeks.

11:07

S… Speaker 3 (EARLY_POD_1-ai)

If we don't reduce adequate weight,

11:09

S… Speaker 3 (EARLY_POD_1-ai)

then we will again talk about this market.

11:11

S… Speaker 3 (EARLY_POD_1-ai)

So again,

11:12

S… Speaker 3 (EARLY_POD_1-ai)

I will tell my physician friends,

11:15

S… Speaker 3 (EARLY_POD_1-ai)

don't be in a hurry.

11:17

S… Speaker 3 (EARLY_POD_1-ai)

Let the patient take his or her time,

11:20

S… Speaker 3 (EARLY_POD_1-ai)

let them understand and it can be started on a later stage at any point.

11:23

S… Speaker 2 (EARLY_POD_1-ai)

Yeah, very well said,

11:25

S… Speaker 2 (EARLY_POD_1-ai)

very very strong.

11:26

S… Speaker 2 (EARLY_POD_1-ai)

A lot of people who once consider weight

11:30

S… Speaker 2 (EARLY_POD_1-ai)

loss are very scared that your bones will be done,

11:33

S… Speaker 2 (EARLY_POD_1-ai)

you will have a lot of bone loss.

11:35

S… Speaker 2 (EARLY_POD_1-ai)

Have you seen anything like this?

11:37

S… Speaker 3 (EARLY_POD_1-ai)

If you have a proper doctor,

11:40

S… Speaker 3 (EARLY_POD_1-ai)

care and therapy medications,

11:41

S… Speaker 3 (EARLY_POD_1-ai)

there are no such problems.

11:44

S… Speaker 3 (EARLY_POD_1-ai)

problems if you are not exercising and you are losing a lot of muscle along

11:48

S… Speaker 3 (EARLY_POD_1-ai)

with it, then you will also loosen all of your both mental with that.

11:52

S… Speaker 3 (EARLY_POD_1-ai)

If you take proper consultations,

11:55

S… Speaker 3 (EARLY_POD_1-ai)

you will follow proper diet,

11:56

S… Speaker 3 (EARLY_POD_1-ai)

proper calcium,

11:59

S… Speaker 3 (EARLY_POD_1-ai)

vitamin D and proper exercise.

12:02

S… Speaker 3 (EARLY_POD_1-ai)

If you are exercising,

12:03

S… Speaker 3 (EARLY_POD_1-ai)

if you are doing resistance training,

12:05

S… Speaker 1 (EARLY_POD_1-ai)

then these problems actually arise.

12:07

S… Speaker 2 (EARLY_POD_1-ai)

When people have already bone density issues or arthritis,

12:10

S… Speaker 2 (EARLY_POD_1-ai)

there are such things.

12:12

S… Speaker 3 (EARLY_POD_1-ai)

Again,

12:13

S… Speaker 3 (EARLY_POD_1-ai)

I believe osteoarthritis is one of the indications for you.

12:15

S… Speaker 3 (EARLY_POD_1-ai)

Because if your weight is reduced,

12:17

S… Speaker 3 (EARLY_POD_1-ai)

the pressure on your joints is reduced and it is actually helping

12:21

S… Speaker 1 (EARLY_POD_1-ai)

those patients.

12:22

S… Speaker 4 (EARLY_POD_1-ai)

Okay.

12:23

S… Speaker 2 (EARLY_POD_1-ai)

So, you suggest this.

12:24

S… Speaker 3 (EARLY_POD_1-ai)

Osteoarthritis is one of the indications for you.

12:28

S… Speaker 4 (EARLY_POD_1-ai)

Okay.

12:28

S… Speaker 2 (EARLY_POD_1-ai)

GLP -1s,

12:30

S… Speaker 2 (EARLY_POD_1-ai)

what age group do you prescribe for weight?

12:34

S… Speaker 2 (EARLY_POD_1-ai)

Lowest and highest.

12:36

S… Speaker 3 (EARLY_POD_1-ai)

So, current indications it is not indicated before

12:40

S… Speaker 3 (EARLY_POD_1-ai)

AT. So,

12:41

S… Speaker 3 (EARLY_POD_1-ai)

I would describe in before I get it.

12:43

S… Speaker 3 (EARLY_POD_1-ai)

So, tiraglutak is one of the drug that has been approved and we can use if

12:47

S… Speaker 3 (EARLY_POD_1-ai)

the patient is obese and is lesser aiding years of age.

12:53

S… Speaker 3 (EARLY_POD_1-ai)

If I go to the elder age group,

12:55

S… Speaker 3 (EARLY_POD_1-ai)

again it depends on the functional status.

12:57

S… Speaker 3 (EARLY_POD_1-ai)

It is not age that is important.

12:59

S… Speaker 1 (EARLY_POD_1-ai)

Okay.

13:00

S… Speaker 3 (EARLY_POD_1-ai)

If your patient is functionally good,

13:02

S… Speaker 3 (EARLY_POD_1-ai)

like is walking,

13:04

S… Speaker 3 (EARLY_POD_1-ai)

you understand that the patient will

13:08

S… Speaker 3 (EARLY_POD_1-ai)

be able to exercise.

13:09

S… Speaker 3 (EARLY_POD_1-ai)

I'll be very happy to describe ELP1 to that patient.

13:13

S… Speaker 3 (EARLY_POD_1-ai)

But a person who is sedentary and I

13:17

S… Speaker 3 (EARLY_POD_1-ai)

understand that the functional status is not that good.

13:21

S… Speaker 1 (EARLY_POD_1-ai)

probably I'd be a bit skeptical.

13:22

S… Speaker 1 (EARLY_POD_1-ai)

Okay.

13:23

S… Speaker 1 (EARLY_POD_1-ai)

Okay.

13:23

S… Speaker 2 (EARLY_POD_1-ai)

That's super helpful.

13:24

S… Speaker 2 (EARLY_POD_1-ai)

All right.

13:25

S… Speaker 2 (EARLY_POD_1-ai)

Thank you so much,

13:27

S… Speaker 1 (EARLY_POD_1-ai)

Dr. Adur.

13:27

S… Speaker 2 (EARLY_POD_1-ai)

You were phenomenal as always.

13:28

S… Speaker 2 (EARLY_POD_1-ai)

Thanks for sharing your insights on GLP -1s.

13:31

S… Speaker 2 (EARLY_POD_1-ai)

Unko safely kaise consume karna chahiye,

13:32

S… Speaker 2 (EARLY_POD_1-ai)

kis guidance mein ranna chahiye.

13:33

S… Speaker 2 (EARLY_POD_1-ai)

So really appreciate you.

13:35

S… Speaker 3 (EARLY_POD_1-ai)

Thank you.

13:35

S… Speaker 1 (EARLY_POD_1-ai)

Thank you.

EARLY_POD_1-ai

_Dürs

Bu transkripsiýa hakda AI-den sora